Jade Biosciences (JBIO) Total Current Liabilities (2020 - 2026)

Jade Biosciences has reported Total Current Liabilities for 7 years, with the latest figure at $22.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 822.3% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $22.3 million (up 822.3% YoY), and the FY2025 full-year result was $16.5 million, up 37.87% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $22.3 million, up from $16.5 million in the prior quarter.
• The five-year high for Total Current Liabilities was $22.4 million in Q3 2025, with the low at $2.4 million in Q1 2025.
• Historically, Total Current Liabilities has averaged $13.0 million across 5 years, with a median of $13.3 million in 2023.
• Annual changes were most pronounced in 2025 — Total Current Liabilities tumbled 84.42% — and 2026, when it jumped 822.3%.
• Jade Biosciences' Total Current Liabilities stood at $7.8 million in 2022, then surged by 126.64% to $17.6 million in 2023, then sank by 31.98% to $12.0 million in 2024, then jumped by 37.87% to $16.5 million in 2025, then surged by 34.78% to $22.3 million in 2026.
• The last three Total Current Liabilities figures came in at $22.3 million (Q1 2026), $16.5 million (Q4 2025), and $22.4 million (Q3 2025), per Business Quant data.